Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE:000623)
China
· Delayed Price · Currency is CNY 15.97
+0.31 (1.98%)
Apr 30, 2025, 3:04 PM CST
SHE:000623 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 1,925 | 1,551 | 1,460 | 1,781 | 1,781 | 1,709 | Upgrade
|
| Depreciation & Amortization | 233.37 | 233.37 | 233.87 | 225.63 | 204.16 | 195.46 | Upgrade
|
| Other Amortization | 4.98 | 4.98 | 5.79 | 4.85 | 4.03 | 3.89 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.67 | 0.67 | -36.16 | -3.16 | 0.94 | 0.64 | Upgrade
|
| Asset Writedown & Restructuring Costs | 65.33 | 65.33 | 3.25 | 1.67 | 2.84 | 25.53 | Upgrade
|
| Loss (Gain) From Sale of Investments | -1,733 | -1,733 | -1,238 | -1,005 | -1,748 | -1,762 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | -4.64 | 11.62 | 5.15 | -0.57 | Upgrade
|
| Other Operating Activities | -209.63 | 94.85 | 184.7 | 188.3 | 143.12 | 127.91 | Upgrade
|
| Change in Accounts Receivable | 268.54 | 268.54 | -304.33 | -189.01 | 6.42 | 58.67 | Upgrade
|
| Change in Inventory | -113.74 | -113.74 | -16.93 | -301.23 | -59.61 | -20.54 | Upgrade
|
| Change in Accounts Payable | -254.64 | -254.64 | -97.31 | 443.58 | 31.83 | 64.19 | Upgrade
|
| Change in Other Net Operating Assets | -32.24 | -32.24 | -118.56 | -610.91 | - | - | Upgrade
|
| Operating Cash Flow | 128.18 | 59.48 | 68.06 | 423.86 | 324.85 | 390.41 | Upgrade
|
| Operating Cash Flow Growth | -55.11% | -12.60% | -83.94% | 30.48% | -16.79% | 2.89% | Upgrade
|
| Capital Expenditures | -231.35 | -273.98 | -419.52 | -270.97 | -313.3 | -227.38 | Upgrade
|
| Sale of Property, Plant & Equipment | 3.83 | 3.92 | 34.61 | 3.08 | 36.94 | 1.42 | Upgrade
|
| Cash Acquisitions | - | - | - | -2.13 | - | -0.95 | Upgrade
|
| Investment in Securities | -12.35 | -0.68 | 524.4 | -1,112 | -1,081 | -96.57 | Upgrade
|
| Other Investing Activities | 707.07 | 707.19 | 624.13 | 828.75 | 646.6 | 508.69 | Upgrade
|
| Investing Cash Flow | 467.2 | 436.44 | 763.62 | -553.21 | -710.4 | 185.21 | Upgrade
|
| Short-Term Debt Issued | - | 3,571 | 653.05 | 641.98 | 302.36 | 306.86 | Upgrade
|
| Total Debt Issued | 2,511 | 3,571 | 653.05 | 641.98 | 302.36 | 306.86 | Upgrade
|
| Short-Term Debt Repaid | - | -3,319 | -651.69 | -374.93 | -342.38 | -21.56 | Upgrade
|
| Total Debt Repaid | -2,257 | -3,319 | -651.69 | -374.93 | -342.38 | -21.56 | Upgrade
|
| Net Debt Issued (Repaid) | 253.8 | 252.23 | 1.36 | 267.05 | -40.02 | 285.3 | Upgrade
|
| Repurchase of Common Stock | -300 | -300 | -150 | -170.04 | -100 | -300.03 | Upgrade
|
| Common Dividends Paid | -994.72 | -1,060 | -400.57 | -377.76 | -255.71 | -252.3 | Upgrade
|
| Other Financing Activities | -122.2 | -2.2 | - | 109.68 | 33.32 | -16.47 | Upgrade
|
| Financing Cash Flow | -1,163 | -1,110 | -549.21 | -171.07 | -362.4 | -283.51 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.21 | -0.25 | -0.72 | -4.12 | 1.73 | 4.02 | Upgrade
|
| Net Cash Flow | -567.96 | -614.29 | 281.75 | -304.55 | -746.23 | 296.13 | Upgrade
|
| Free Cash Flow | -103.17 | -214.5 | -351.46 | 152.89 | 11.54 | 163.02 | Upgrade
|
| Free Cash Flow Growth | - | - | - | 1224.31% | -92.92% | 3.80% | Upgrade
|
| Free Cash Flow Margin | -4.35% | -8.22% | -10.19% | 5.33% | 0.50% | 7.24% | Upgrade
|
| Free Cash Flow Per Share | -0.09 | -0.18 | -0.27 | 0.12 | 0.01 | 0.13 | Upgrade
|
| Cash Income Tax Paid | 218.53 | 218.53 | 304.37 | 205.93 | 207.45 | 286.46 | Upgrade
|
| Levered Free Cash Flow | -414.2 | -254.86 | -526.06 | -2.86 | -139.08 | 12.79 | Upgrade
|
| Unlevered Free Cash Flow | -380.4 | -197.3 | -435.84 | 86.51 | -57.53 | 92.05 | Upgrade
|
| Change in Net Working Capital | 255.1 | 61.42 | 340.06 | -45.81 | -43.92 | -161.17 | Upgrade
|
Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.